Myosin Light Chain Kinase Inhibitor Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myosin Light Chain Kinase Inhibitor Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice
Authors
Keywords
MLCK inhibitor, Dextran sulfate sodium, Colitis, Permeability
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 58, Issue 1, Pages 107-114
Publisher
Springer Nature
Online
2012-07-10
DOI
10.1007/s10620-012-2304-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis
- (2012) Walter Fries et al. International Journal of Medical Sciences
- HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort
- (2010) Suzanne van Sommeren et al. INFLAMMATORY BOWEL DISEASES
- Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity
- (2010) Christopher R. Weber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caveolin-1–dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo
- (2010) Amanda M. Marchiando et al. JOURNAL OF CELL BIOLOGY
- Effect of an Extract Based on the Medicinal Mushroom Agaricus blazei Murill on Expression of Cytokines and Calprotectin in Patients with Ulcerative Colitis and Crohn’s disease
- (2010) D. T. Førland et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Review: Current directions of biologic therapies in inflammatory bowel disease
- (2010) Catherine Reenaers et al. Therapeutic Advances in Gastroenterology
- Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
- (2009) Rudolf Mennigen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohnʼs disease
- (2009) Nobuhiko Kamada et al. INFLAMMATORY BOWEL DISEASES
- Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo
- (2009) E. Miyauchi et al. JOURNAL OF DAIRY SCIENCE
- Traumatic Brain Injury and Intestinal Dysfunction: Uncovering the Neuro-Enteric Axis
- (2009) Vishal Bansal et al. JOURNAL OF NEUROTRAUMA
- Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
- (2008) Norihiro Nishimoto et al. ARTHRITIS AND RHEUMATISM
- Protective Effect of Octreotide and Infliximab in an Experimental Model of Indomethacin-Induced Inflammatory Bowel Disease
- (2008) Dídia H. Bismara Cury et al. DIGESTIVE DISEASES AND SCIENCES
- Targeted Epithelial Tight Junction Dysfunction Causes Immune Activation and Contributes to Development of Experimental Colitis
- (2008) Liping Su et al. GASTROENTEROLOGY
- Modulation of the Th1/Th2 Balance by Infliximab Improves Hyperthyroidism Associated with a Flare-up of Ulcerative Colitis
- (2008) Kayoko Matsumura et al. INFLAMMATORY BOWEL DISEASES
- Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease
- (2008) Reikei Matsuda et al. INFLAMMATORY BOWEL DISEASES
- Intestinal barrier dysfunction in inflammatory bowel diseases
- (2008) Michael A. McGuckin et al. INFLAMMATORY BOWEL DISEASES
- Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-α-induced regulation of myosin light chain kinase gene activity
- (2008) Dongmei Ye et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
- (2007) Klaus Kannengiesser et al. INFLAMMATORY BOWEL DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started